BDBM511819 (1R,3S,5R)-2-(2-(3-acetyl-7-methyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(6-bromo-3-methylpyridin-2- ((ethylamino)methyl)-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 132::US11708351, Compound 132

SMILES CCNC[C@]12C[C@H]1N([C@@H](C2)C(=O)Nc1nc(Br)ccc1C)C(=O)Cn1nc(C(C)=O)c2cc(cc(C)c12)-c1cnc(C)nc1

InChI Key InChIKey=SBZAIVRBYGXTJX-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 511819   

TargetComplement factor D(Human)
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM511819(US11084800, Cpd No. 132 | (1R,3S,5R)-2-(2-(3-acety...)
Affinity DataIC50: 1.00E+3nMAssay Description:Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2022
Entry Details
US Patent

TargetComplement factor D(Human)
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM511819(US11084800, Cpd No. 132 | (1R,3S,5R)-2-(2-(3-acety...)
Affinity DataIC50: 1.00E+3nMAssay Description:Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/27/2023
Entry Details
US Patent